Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Depotech(depo) -- Ignore unavailable to you. Want to Upgrade?

To: chirodoc who wrote (304)	12/3/1997 9:03:00 AM
From: Cymeed	Read Replies (1) \| Respond to of 887

Agreed, hope you and I are the Buffets today since we both own CKFR. I don't like MSFT because I am not confident MSFT can maintain that 30% growth going forward. They are more and more like a matured company, not a vivid growth company. If what Tom etl said here is true, DEPO should have a very bright future as they are the first to use this highly innovative and effective drug delivery system. Somebody has asked the question already, but I don't seem to have got an answer from Tom. When does the patent of this new drug delivery system is going to expire ? Is there any way for Depo to prtect from imitations if it does expire ? Do you know anything in this respect, Doc ? Or is Tom here today ?